Description
Vinings Holdings Inc., a biopharmaceutical company, engages in the acquisition, development, and commercialization of branded and generic pharmaceutical products. Its product portfolio consists of two approved drugs and two clinical stage drugs. The company offers Conjupri (levamlodipine) tablets for the treatment of hypertension; and Consensi (amlodipine and celecoxib) tablets to treat pain caused by osteoarthritis. Its clinical-stage drug candidates include CPT15050; and CPT60621, a focus on Parkinson's Disease. The company has partnership with Burke Therapeutics for sales, marketing, distribution, contracting, and pricing for conjupri; and partnership with Vici Health Sciences, LLC and Coeptis Pharmaceuticals would co-develop and share ownership rights to CPT60621. The company is based in Wexford, Pennsylvania.
